• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APYX MEDICAL CORPORATION RENUVION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APYX MEDICAL CORPORATION RENUVION Back to Search Results
Model Number APYX-27-TP
Device Problems Improper or Incorrect Procedure or Method (2017); Patient Device Interaction Problem (4001)
Patient Problem Chest Pain (1776)
Event Date 01/23/2022
Event Type  Injury  
Event Description
It was reported that a (b)(6) female patient with a history of rhinoplasty and breast implants, underwent liposuction followed by renuvion treatment.Undermining was performed with vibrasat pro and there were 2 liters of 1mg of adrenaline infused.3 passes on antegrade and retrograde were performed to the abdomen, thighs, back, arms and buttocks.6.5 liters of asperation was performed on multiple locations for 3.5 hours.The procedure was completed uneventful.However, the following day, the patient complaint of violent chest and dorsal pain while showering.The patient suffered from pain for four days and eventually fainted.The patient was hospitalized due to pain.It was further determined that there was only one single incision site at the arms where treatment was performed.The patient was scanned and a pneumomediastinum was diagnosed around right chest and heart.There was no embolism and no oxygen compromise.The patient was only treated for pain.The patient is recovering at home.The likely cause of this incident is due to not enough adequate incision sites for gas egress.It was further determined that the surgeon performs 3 passes and uses the liposuction cannula for suction.Per apyx medical, advisory board member, suction with a liposuction cannula can compress tissue and block egress points.Therefore, true undermining is important, otherwise compression of tissue occurs trapping gas and causing direct access to the mediastinum.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RENUVION
Type of Device
RENUVION
Manufacturer (Section D)
APYX MEDICAL CORPORATION
5115 ulmerton road
clearwater FL 33760 4004
Manufacturer Contact
aylin canlar
5115 ulmerton road
clearwater, FL 33760-4004
7273842323
MDR Report Key13695868
MDR Text Key287119792
Report Number3007593903-2022-00007
Device Sequence Number1
Product Code GEI
UDI-Device Identifier00607151050160
UDI-Public00607151050160
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K191542
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAPYX-27-TP
Device Catalogue NumberAPYX-27-TP
Was Device Available for Evaluation? No
Date Manufacturer Received02/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age31 YR
Patient SexFemale
-
-